Drug Discovery Informatics Market Size to Reach USD 9.89 Bn by 2033

According to a recent research report titled “Drug Discovery Informatics Market (By Service: Sequence Analysis Platform, Molecular Modeling, Clinical Trial Data Management, Docking; By End-User: Pharmaceutical and Biotechnological Companies, Contract Research Organization (CRO)) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033″ published by Precedence Research, the global drug discovery informatics market size is projected to touch around USD 9.89 billion by 2033 and growing at a CAGR of 11% over the forecast period 2024 to 2033. This comprehensive study examines various factors and their impact on the growth of the drug discovery informatics market.

Key Points

• North America held the dominating share of 40% in 2023.
• Asia Pacific is observed to witness the fastest growth at a CAGR of 11.9% during the forecast period.
• By service, the sequence analysis platform segment dominated the market with the highest share in 2023.
• By service, the molecular modeling segment is observed to witness a significant rate of expansion during the forecast period.
• By end-user, pharmaceutical and biotechnology companies dominated the market in 2023.
• By end-user, the contract research organization segment is expected to witness the fastest rate of expansion during the forecast period.

The report primarily focuses on the volume and value of the drug discovery informatics market at the global, regional, and company levels. At the global level, the report analyzes historical data and future prospects to present an overview of the overall market size. Regionally, the study emphasizes key regions such as North America, Europe, the Middle East & Africa, Latin America, and others.

Furthermore, the research report provides specific segmentations based on regions (countries), companies, and all market segments. This analysis offers insights into the growth and revenue trends during the historical period of 2017 to 2032, as well as the projected period. By understanding these segments, it becomes possible to identify the significance of different factors that contribute to market growth.

Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3782

The research also highlights significant progressions in both organic and inorganic growth strategies within the global drug discovery informatics market. Numerous companies are placing emphasis on new product launches, gaining product approvals, and implementing various business expansion tactics. Moreover, the report presents detailed profiles of firms operating in the drug discovery informatics market, along with their respective market strategies. Additionally, the study concentrates on prominent industry participants, furnishing details such as company profiles, product offerings, financial updates, and noteworthy advancements.

Drug Discovery Informatics Market Scope

Also read: AI in Food and Beverages Market Size to Attain USD 214.62 Bn by 2033

Major Key Points Covered in Report:

Executive Summary: It includes key trends of the electric vehicle fuel cell market related to products, applications, and other crucial factors. It also provides analysis of the competitive landscape and CAGR and market size of the electric vehicle fuel cell market based on production and revenue.

Production and Consumption by Region: It covers all regional markets to which the research study relates. Prices and key players in addition to production and consumption in each regional market are discussed.

Key Players: Here, the report throws light on financial ratios, pricing structure, production cost, gross profit, sales volume, revenue, and gross margin of leading and prominent companies competing in the Electric vehicle fuel cell market.

Market Segments: This part of the report discusses product, application and other segments of the electric vehicle fuel cell market based on market share, CAGR, market size, and various other factors.

Research Methodology: This section discusses the research methodology and approach used to prepare the report. It covers data triangulation, market breakdown, market size estimation, and research design and/or programs.

Market Key Players

The report incorporates company profiles of key players in the market. These profiles encompass vital information such as product portfolio, key strategies, and a comprehensive SWOT analysis for each player. Additionally, the report presents a matrix illustrating the presence of each prominent player, enabling readers to gain actionable insights. This facilitates a thoughtful assessment of the market status and aids in predicting the level of competition in the drug discovery informatics market.

Drug Discovery Informatics Market Companies

• Collaborative Drug Discovery, Inc.
• Eurofins DiscoverX Products
• Jubliant Biosys
• Selvita
• Novo Informatics Pvt. Ltd.
• ChemAxon Ltd.
• Albany Molecular Research Inc.
• Certara
• Boehringer Ingelheim International GmbH
• Infosys Ltd.
• Charles River Laboratories
• Oracle
• Accenture
• Agilent Technologies, Inc.
• Illumina, Inc.

Market Segmentation

By Service

• Sequence Analysis Platform
• Molecular Modeling
• Clinical Trial Data Management
• Docking

By End-User

• Pharmaceutical and Biotechnological Companies
• Contract Research Organization (CRO)

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Table of Content:

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Drug Discovery Informatics Market 

5.1. COVID-19 Landscape: Drug Discovery Informatics Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Drug Discovery Informatics Market, By Service

8.1. Drug Discovery Informatics Market, by Service, 2024-2033

8.1.1. Sequence Analysis Platform

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Molecular Modeling

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Clinical Trial Data Management

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Docking

8.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Drug Discovery Informatics Market, By End-User

9.1. Drug Discovery Informatics Market, by End-User, 2024-2033

9.1.1. Pharmaceutical and Biotechnological Companies

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Contract Research Organization (CRO)

9.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Drug Discovery Informatics Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Service (2021-2033)

10.1.2. Market Revenue and Forecast, by End-User (2021-2033)

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Service (2021-2033)

10.1.3.2. Market Revenue and Forecast, by End-User (2021-2033)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Service (2021-2033)

10.1.4.2. Market Revenue and Forecast, by End-User (2021-2033)

10.2. Europe

10.2.1. Market Revenue and Forecast, by Service (2021-2033)

10.2.2. Market Revenue and Forecast, by End-User (2021-2033)

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Service (2021-2033)

10.2.3.2. Market Revenue and Forecast, by End-User (2021-2033)

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Service (2021-2033)

10.2.4.2. Market Revenue and Forecast, by End-User (2021-2033)

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Service (2021-2033)

10.2.5.2. Market Revenue and Forecast, by End-User (2021-2033)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Service (2021-2033)

10.2.6.2. Market Revenue and Forecast, by End-User (2021-2033)

10.3. APAC

10.3.1. Market Revenue and Forecast, by Service (2021-2033)

10.3.2. Market Revenue and Forecast, by End-User (2021-2033)

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Service (2021-2033)

10.3.3.2. Market Revenue and Forecast, by End-User (2021-2033)

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Service (2021-2033)

10.3.4.2. Market Revenue and Forecast, by End-User (2021-2033)

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Service (2021-2033)

10.3.5.2. Market Revenue and Forecast, by End-User (2021-2033)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Service (2021-2033)

10.3.6.2. Market Revenue and Forecast, by End-User (2021-2033)

10.4. MEA

10.4.1. Market Revenue and Forecast, by Service (2021-2033)

10.4.2. Market Revenue and Forecast, by End-User (2021-2033)

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Service (2021-2033)

10.4.3.2. Market Revenue and Forecast, by End-User (2021-2033)

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Service (2021-2033)

10.4.4.2. Market Revenue and Forecast, by End-User (2021-2033)

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Service (2021-2033)

10.4.5.2. Market Revenue and Forecast, by End-User (2021-2033)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Service (2021-2033)

10.4.6.2. Market Revenue and Forecast, by End-User (2021-2033)

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Service (2021-2033)

10.5.2. Market Revenue and Forecast, by End-User (2021-2033)

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Service (2021-2033)

10.5.3.2. Market Revenue and Forecast, by End-User (2021-2033)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Service (2021-2033)

10.5.4.2. Market Revenue and Forecast, by End-User (2021-2033)

Chapter 11. Company Profiles

11.1. Collaborative Drug Discovery, Inc. Abbott

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Eurofins DiscoverX Products

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Jubliant Biosys

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Selvita

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Novo Informatics Pvt. Ltd.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. ChemAxon Ltd.

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Albany Molecular Research Inc.

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. Certara

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Boehringer Ingelheim International GmbH

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Infosys Ltd.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Why should you invest in this report?

This report presents a compelling investment opportunity for those interested in the global drug discovery informatics market. It serves as an extensive and informative guide, offering clear insights into this niche market. By delving into the report, you will gain a comprehensive understanding of the various major application areas for drug discovery informatics. Furthermore, it provides crucial information about the key regions worldwide that are expected to experience substantial growth within the forecast period of 2023-2030. Armed with this knowledge, you can strategically plan your market entry approaches.

Moreover, this report offers a deep analysis of the competitive landscape, equipping you with valuable insights into the level of competition prevalent in this highly competitive market. If you are already an established player, it will enable you to assess the strategies employed by your competitors, allowing you to stay ahead as market leaders. For newcomers entering this market, the extensive data provided in this report is invaluable, providing a solid foundation for informed decision-making.

Some of the key questions answered in this report:       

• What is the size of the overall Drug discovery informatics market and its segments?
• What are the key segments and sub-segments in the market?
• What are the key drivers, restraints, opportunities and challenges of the Drug discovery informatics market and how they are expected to impact the market?
• What are the attractive investment opportunities within the Drug discovery informatics market?
• What is the Drug discovery informatics market size at the regional and country-level?
• Who are the key market players and their key competitors?
• What are the strategies for growth adopted by the key players in Drug discovery informatics market?
• What are the recent trends in Drug discovery informatics market? (M&A, partnerships, new product developments, expansions)?
• What are the challenges to the Drug discovery informatics market growth?
• What are the key market trends impacting the growth of Drug discovery informatics market?

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts